According to Hualan Biological Engineering's latest financial reports and stock price the company's current Operating Margin is 33.72%. At the end of 2022 the company had an Operating Margin of 31.62%.
Year | Operating Margin | Change |
---|---|---|
2022 | 31.62% | -16.91% |
2021 | 38.06% | -10.98% |
2020 | 42.75% | -1.77% |
2019 | 43.52% | 0.73% |
2018 | 43.20% | 10.79% |
2017 | 39.00% | -16.56% |
2016 | 46.74% | -0.68% |
2015 | 47.05% | -6.8% |
2014 | 50.49% | 0.57% |
2013 | 50.20% | 30.88% |
2012 | 38.36% | -19.84% |
2011 | 47.85% | -26.26% |
2010 | 64.89% | 1.15% |
2009 | 64.15% | 40.09% |
2008 | 45.80% | 25.43% |
2007 | 36.51% | 41.96% |
2006 | 25.72% | 56.12% |
2005 | 16.47% | 17.7% |
2004 | 14.00% | -15.23% |
2003 | 16.51% | -15.49% |
2002 | 19.54% | 34.62% |
2001 | 14.51% |
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.